Medirom Healthcare Technologies Inc. held its 25th Ordinary General Meeting of Shareholders on May 30, 2025. At the meeting, shareholders approved the company's non-consolidated financial statements for the 25th fiscal year, agreed to reduce the registered paid-in capital by re-classifying certain amounts as other capital surplus, and re-elected four directors to the Board of Directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.